CN Energy Group. Inc. Launches PATHENBOT Robotics Solutions Platform, Website

Insider Brief

  • CN Energy Group has launched PATHENBOT, a new robotics solutions platform aimed at delivering customizable intelligent automation to small and mid-sized industrial, logistics, and catering businesses in North America.
  • The subsidiary plans to integrate robotics, software, and AI technologies to meet rising regional demand for automation and expand the company’s strategic footprint in intelligent systems.
  • PATHENBOT’s official website is now live, marking the next stage in CNEY’s development of its robotics and automation initiatives.

PRESS RELEASE — CN Energy Group. Inc. (“CNEY” or the “Company”) (NASDAQ: CNEY), a Nasdaq-listed company, today announced that its wholly owned subsidiary, PATHENBOT Group Inc. (“PATHENBOT”), has launched its robotics solutions platform and its official website (www.pathenbot.com). This launch represents the next step in the development of PATHENBOT’s intelligent robotics initiatives.

The North American intelligent automation market continues to see increased demand. PATHENBOT’s mission is to provide customizable intelligent robotics products and related automation services to small and medium-sized industrial, logistics, and catering businesses in North America. PATHENBOT intends to integrate robotics, software, and artificial intelligence technologies to provide automation solutions as part of the Company’s continued development.

Wenhua Liu, CEO of CNEY, commented: “We are pleased to announce the launch of PATHENBOT’s robotics solutions platform and official website, which reflect our continued efforts to advance the Company’s strategic initiatives and support our broader growth plans.

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

gloved hands drawing vaccine from vial with syringe
Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery

Insider Brief PRESS RELEASE — Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the launch of the Open

Japan’s AI Strategy: From Society 5.0 to Generative AI

A policy analysis from August 2026 Japan was arguing about the shape of its AI future before most countries had a strategy at all. In

Data Centers
Top U.S. States for AI Data Centers And Infrastructure Growth

Insider Brief The best U.S. states for AI data center growth aren’t necessarily those with the most facilities, as access to electricity, water and room

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

$ 0 M

Seed round tracked

Gitar — Code Validation

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Subscribe today for the latest news about the AI landscape